Centivax is developing universal flu vaccines designed to protect against all strains of influenza—past, present, and future. In this interview, we speak with Jacob Glanville, the company’s co-founder and CEO.
Subscribe to Asimov Press: https://press.asimov.com
Produced and edited by Chris Gates, crgstudio.co
00:49 Why flu vaccines need constant updating
03:07 How influenza infects a cell
06:39 Why our immune system doesn’t generate broadly-neutralizing antibodies
16:07 Mutations and animals
23:42 What is vaccine efficacy?
28:55 Designing a universal flu vaccine
37:40 The idea behind Centivax
44:16 Clinical trials
57:33 The business case for eradication
1:03:26 How to eradicate the flu
1:07:26 Could we make broad vaccines for the common cold?
1:09:07 Building a universal snake antivenom
1:23:09 Antivenom cocktails